Frontage Q2 2023 Newsletter

Keep reading for some 2023 Q1 Frontage highlights and Q2 events not to be missed!

Upcoming Conferences and Events

• CPhI North America: April 25-27, 2023
• ASGCT: May 16-20, 2023
• OCT East Coast: May 23-24, 2023
• ASCO: June 2-6, 2023
• Bio International: June 5-8, 2023
• WRIB: June 19-23, 2023
• DIA: June 25-29, 2023

NEW Clinical Services Overview

Frontage provides comprehensive clinical trial support to ensure rapid start-up and execution of your programs. With 25+ years of experience, we deliver services ranging from study conduct to data reporting and preparation of final reports, suitable for FDA submission.

→ Download Clinical Services Fact Sheet Here

NEW Discovery Services Overview

Frontage’s discovery team is comprised of experienced medicinal chemists, biologists, and DMPK scientists that help Sponsors generate hits and leads. We profile, optimize, and advance the compounds to an IND candidate.

→ Download Discovery Services Fact Sheet Here

Browse the Latest News

Central Lab Test Menu

• Download the latest central lab test menu, listing our complete testing capabilities including infectious diseases, hematology, chemistry, immunoassays, therapeutic drug monitoring, drug abuse screening, and more.

→ Download Here

2023 Assay List

• Frontage offers an impressive list of assays supporting biologics, small molecules, and biomarkers. Download our ever-growing list of assays to find what you need.

→ Download Here

Gyrolab Testing

• In this white paper, we show testing of two critical parameters for the method validation of Gyrolab: 1) carryover contamination and 2) after MRD (minimum required dilution) stability.

→ Download Here

Implementing ICH M10: Bioanalytical Method Validation Guidance

• Adopted on May 24, 2022, the International Council for Harmonisation (ICH) has released a new guideline to standardize bioanalytical method validation (BMV) practices.

→  Read more here

Product Development of Sterile Nanoemulsions

• Nanoemulsions have been of great interest to pharmaceutical companies as the world’s nanotechnology industry could be worth 80 billion dollars and nearing a 17% growth rate by 2024.

→  Read more here

Gyrolab: Design, Challenges, and Advantages

• Gyros Protein Technologies AB developed Gyrolab platforms using “reproducible nanoliter microfluidics and sequential CD processing” for efficient immunoassay runs.

→  Read more here

Contact Us

Join our Team